Cardiff Oncology, Inc. (CRDF) financial statements and ratios from SEC XBRL: revenue $593000.00 (TTM), net margin -7732.0%, revenue growth -13.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $593000.00 |
| Net Margin | -7732.0% |
| Revenue Growth (YoY) | -13.2% |
| EPS Growth (YoY) | -27.4% |
| FCF Growth (YoY) | 0.5% |
| Price / Book | 2.58 |
| Price / Sales | 223.75 |
| FCF Yield | -81.9% |
| Altman Z-Score | -9.29 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CRDF overview · CRDF earnings · CRDF KPIs · CRDF investor relations · CRDF ownership · CRDF peers · CRDF filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.